Literature DB >> 11379194

[New information on the pathophysiology of atherosclerosis].

Z Reiner1, E Tedeschi-Reiner.   

Abstract

The past decade has witnessed enormous progress in our understanding of the nature of this process. The development of an atherosclerotic plaque is a complex process which begins with endothelial dysfunction, the trigger for which are factors such as hypercholesterolemia, smoking, hypertension, hyperhomocysteinemia and impaired glucose metabolism. This dysfunction includes increased endothelial permeability to lipoproteins and other plasma constituents, which is mediated by NO, PDGF, prostacyclin, angiotensin II and endothelin; up-regulation of endothelial adhesion molecules including VCAM-1, ICAM-1, and selectins and migration of leukocytes and monocytes-macrophages in the subendothelial space mediated by oxidized LDL, MCP-1, PDGF and MCSF. The next step includes smooth-muscle cells migration (stimulated by PDGF and TGF-beta), T-cell activation (mediated by TNF-alpha and IL-2), formation of foam-cells from macrophages (mediated by oxidized LDL, MCSF, TNF-alpha and IL-1) and platelet adherence and aggregation (stimulated by thromboxane A2, tissue factor etc). The smooth muscle cells form a fibrous cap which confers mechanical stability of the plaque and separates the lipid rich thrombogenic core from the lumen and circulating blood. Whether a plaque will remain intact and therefore stable or rupture and lead to thrombosis causing an acute coronary syndrome (MI, unstable angina pectoris) depends upon a number of factors, the most important of which is its composition. Plaque size plays only a minor role in determining risk of an acute coronary syndrome. Rupture of the fibrous cap occurs due to thinning of the cap caused by an influx and activation of macrophages which release metalloproteinases and other proteolytic enzymes (stimulated by inflammatory cells, particularly T-lymphocytes). These enzymes cause degradation of the fibrous tissue of the cap which can result in thrombous formation and occlusion of the artery. Stable plaques have a thick fibrous cap, a small lipid core, and few inflammatory cells. In contrast, vulnerable plaques have a high lipid content, numerous inflammatory cells, and a thin fibrous cap with reduced collagen and vascular smooth muscle cells in it. Although vulnerable plaques are believed to account for only a small number of all coronary atheromas, they are responsible for most acute coronary events.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11379194

Source DB:  PubMed          Journal:  Lijec Vjesn        ISSN: 0024-3477


  6 in total

Review 1.  Chronic Inflammatory Diseases and Endothelial Dysfunction.

Authors:  Xavier Castellon; Vera Bogdanova
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

2.  New mechanisms of antiplatelet activity of nifedipine, an L-type calcium channel blocker.

Authors:  Tz-Chong Chou
Journal:  Biomedicine (Taipei)       Date:  2014-11-18

3.  Tanshinone II A stabilizes vulnerable plaques by suppressing RAGE signaling and NF-κB activation in apolipoprotein-E-deficient mice.

Authors:  Dong Zhao; Lufang Tong; Lixin Zhang; Hong Li; Yingxin Wan; Tiezhong Zhang
Journal:  Mol Med Rep       Date:  2016-11-01       Impact factor: 2.952

Review 4.  The mechanisms of vascular aging.

Authors:  Shan Wang; Song Hu; Yongjun Mao
Journal:  Aging Med (Milton)       Date:  2021-05-21

5.  Screening for subclinical atherosclerosis by noninvasive methods in asymptomatic patients with risk factors.

Authors:  Xavier Castellon; Vera Bogdanova
Journal:  Clin Interv Aging       Date:  2013-05-28       Impact factor: 4.458

6.  Pathophysiology and Classification of Cardiovascular Diseases Caused by Atherosclerosis.

Authors:  Željko Reiner
Journal:  EJIFCC       Date:  2003-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.